Recent advances in the development of selective human MAO-B inhibitors: (Hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazinesSECCI, Daniela; BOLASCO, Adriana; CARRADORI, Simone et al.European journal of medicinal chemistry. 2012, Vol 58, pp 405-417, issn 0223-5234, 13 p.Article

Seeing With the Eyes Shut: Neural Basis of Enhanced Imagery Following Ayahuasca IngestionDE ARAUJO, Draulio B; RIBEIRO, Sidarta; CECCHI, Guillermo A et al.Human brain mapping. 2012, Vol 33, Num 11, pp 2550-2560, issn 1065-9471, 11 p.Article

Treatment of depression with atypical features : A meta-analytic approachHENKEL, Verena; MERGL, Roland; ALLGAIER, Antje-Kathrin et al.Psychiatry research. 2006, Vol 141, Num 1, pp 89-101, issn 0165-1781, 13 p.Article

Remission in depression : definition and initial treatment approachesISRAEL, Joshua A.Journal of psychopharmacology. Supplement to ... 2006, Vol 20, Num 3, pp 5-10, issn 1359-7868, 6 p.Article

Monoamine oxidase inhibitors I-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicitySEYMOUR, C. B; MOTHERSILL, C; MOONEY, R et al.British journal of cancer. 2003, Vol 89, Num 10, pp 1979-1986, issn 0007-0920, 8 p.Article

Synthesis and evaluation of aplysinopsin analogs as inhibitors of human monoamine oxidase A and BLEWELLYN, Kevin; BIALONSKA, Dobroslawa; CHAURASIYA, Narayan D et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 15, pp 4926-4929, issn 0960-894X, 4 p.Article

Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brainsNAOI, Makoto; MARUYAMA, Wakako; NAGY, Georgy M et al.Neurotoxicology (Park Forest South). 2004, Vol 25, Num 1-2, pp 193-204, issn 0161-813X, 12 p.Article

CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicityKEN GILLMAN, P.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 3, pp 429-436, issn 0269-8811, 8 p.Article

MAOI efficacy and safety in advanced stage treatment-resistant depression- : a retrospective studyAMSTERDAM, Jay D; SHULTS, Justine.Journal of affective disorders. 2005, Vol 89, Num 1-3, pp 183-188, issn 0165-0327, 6 p.Article

Anticonvulsant action of indazoleMATSUMURA, Nobuko; KIKUCHI-UTSUMI, Kazue; SAKAMAKI, Kentaro et al.Epilepsy research. 2013, Vol 104, Num 3, pp 203-216, issn 0920-1211, 14 p.Article

Inhibition du cytochrome P-450 des microsomes hépatiques de rat par des inhibiteurs de la monoamine oxydaseDupont, Hervé; Le Goffic, François.1987, 150 p.Thesis

Supercritical fluid extraction of monoamine oxidase inhibitor from antler velvetRAN ZHOU; JINYU WANG; SHUFEN LI et al.Separation and purification technology. 2009, Vol 65, Num 3, pp 275-281, issn 1383-5866, 7 p.Article

A review of serotonin toxicity data : Implications for the mechanisms of antidepressant drug action : TherapeuticsGILLMAN, P. Ken.Biological psychiatry (1969). 2006, Vol 59, Num 11, pp 1046-1051, issn 0006-3223, 6 p.Article

Tricyclic antidepressant pharmacology and therapeutic drug interactions updatedGILLMAN, P. K.British journal of pharmacology. 2007, Vol 151, Num 6, pp 737-748, issn 0007-1188, 12 p.Article

Acute myocarditis after massive phenelzine overdoseWARING, W. Stephen; WALLACE, William A. H.European journal of clinical pharmacology. 2007, Vol 63, Num 11, pp 1007-1009, issn 0031-6970, 3 p.Article

Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-A inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatumKITANAKA, N; KITANAKA, J; TAKEMURA, M et al.Neuroscience. 2005, Vol 130, Num 2, pp 295-308, issn 0306-4522, 14 p.Article

Neuroprotection by the multitarget iron chelator M30 on age-related alterations in miceKUPERSHMIDT, Lana; AMIT, Tamar; BAR-AM, Orit et al.Mechanisms of ageing and development. 2012, Vol 133, Num 5, pp 267-274, issn 0047-6374, 8 p.Article

Inhibitory Effect of Acetylcholine on Monoamine Oxidase A and B Activity in Different Parts of Rat BrainOSMAN, Mohamed Y; OSMAN, Hassan M. Y.Arzneimittel-Forschung. 2008, Vol 58, Num 10, pp 493-496, issn 0004-4172, 4 p.Article

Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in ratsIZUMI, Takeshi; IWAMOTO, Nobuyuki; KITAICHI, Yuji et al.European journal of pharmacology. 2006, Vol 532, Num 3, pp 258-264, issn 0014-2999, 7 p.Article

Effect of oral linezolid on the pressor response to intravenous tyramineCANTARINI, Mireille V; PAINTER, Catherine J; GILMORE, Elaine M et al.British journal of clinical pharmacology. 2004, Vol 58, Num 5, pp 470-475, issn 0306-5251, 6 p.Article

Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain : Potential relevance to antidepressant responseHEYDENDAEL, Willem; JACOBSON, Lauren.Brain research. 2008, Vol 1238, pp 93-107, issn 0006-8993, 15 p.Article

Enantiomers of new synthetic pyrrolylphenylethanoneamine mono-amino oxidase inhibitor compounds: Analytical and semipreparative HPLC separations, and chiroptical characteristicsTORRE, F. La; CIRILLI, R; COSTI, R et al.Chromatographia (Wiesbaden). 2004, Vol 60, Num 3-4, pp 171-178, issn 0009-5893, 8 p.Article

The selegiline transdermal system in major depressive disorder : A systematic review of safety and tolerabilityROBINSON, Donald S; AMSTERDAM, Jay D.Journal of affective disorders. 2008, Vol 105, Num 1-3, pp 15-23, issn 0165-0327, 9 p.Article

LC determination of coumarm-3-acyl derivatives for evaluation of the stability and monoamine oxidase inhibition mechanismCHIMENTI, F; SECCI, D; BOLASCO, A et al.Chromatographia (Wiesbaden). 2005, Vol 61, Num 9-10, pp 519-522, issn 0009-5893, 4 p.Article

Evidence-based medical review update : Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004GOETZ, Christopher G; POEWE, Werner; RASCOL, Olivier et al.Movement disorders. 2005, Vol 20, Num 5, pp 523-539, issn 0885-3185, 17 p.Article